EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, IVERIC bio's enterprise value is $5,010.02 Mil.
IVERIC bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil. Therefore, IVERIC bio's EV-to-Revenue for today is .
The historical rank and industry rank for IVERIC bio's EV-to-Revenue or its related term are showing as below:
During the past 12 years, the highest EV-to-Revenue of IVERIC bio was 66.95. The lowest was -10.60. And the median was 0.53.
ISEE's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.37 * Ranked among companies with meaningful EV-to-Revenue only.
As of today (2024-05-13), IVERIC bio's stock price is $39.95.
IVERIC bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00. Therefore, IVERIC bio's PS Ratio for today is .
IVERIC bio EV-to-Revenue Historical Data
The historical data trend for IVERIC bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IVERIC bio's EV-to-Revenue
For the Biotechnology subindustry, IVERIC bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVERIC bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IVERIC bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where IVERIC bio's EV-to-Revenue falls into.
IVERIC bio's current Enterprise Value is $5,010.02 Mil.
IVERIC bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVERIC bio's share price for today is $39.95.
IVERIC bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVERIC bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of IVERIC bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ISEE has been successfully added to your 